Open68.370 | Close- |
Vol / Avg.2.900M / 5.219M | Mkt Cap211.298B |
Day Range68.005 - 68.505 | 52 Wk Range52.655 - 76.560 |
AstraZeneca Stock (NASDAQ: AZN) stock price, news, charts, stock research, profile.
Open68.370 | Close- |
Vol / Avg.2.900M / 5.219M | Mkt Cap211.298B |
Day Range68.005 - 68.505 | 52 Wk Range52.655 - 76.560 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.950 | 1.075 | |||||
REV | 10.960B | 11.416B | 456.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-08 | Erste Group | - | Downgrades | BuyHold | - | - | - |
2023-08-01 | BMO Capital | Etzer Darout | Maintains | OutperformOutperform | Raises | 81.00 | 83.00 |
2023-05-26 | Argus Research | Jasper Hellweg | Maintains | BuyBuy | Lowers | 85.00 | 80.00 |
2023-04-13 | Argus Research | Jasper Hellweg | Maintains | Buy | Raises | 75.00 | 85.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
AZN | AstraZeneca | 1.71% | 211.3B |
NVO | Novo Nordisk | 0.43% | 410.1B |
RETA | Reata Pharmaceuticals | 0.06% | 6.6B |
JNJ | Johnson & Johnson | -0.45% | 387.5B |
MRK | Merck & Co | -0.11% | 270.5B |
You can purchase shares of AstraZeneca (NASDAQ: AZN) through any online brokerage.
Other companies in AstraZeneca’s space includes: Novo Nordisk (NYSE:NVO), Reata Pharmaceuticals (NASDAQ:RETA), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK) and Novartis (NYSE:NVS).
The latest price target for AstraZeneca (NASDAQ: AZN) was reported by Erste Group on Friday, September 8, 2023. The analyst firm set a price target for 0.00 expecting AZN to fall to within 12 months (a possible -100.00% downside). 7 analyst firms have reported ratings in the last year.
The stock price for AstraZeneca (NASDAQ: AZN) is $68.165 last updated Today at September 22, 2023 at 5:55 PM UTC.
A quarterly cash dividend of $0.47 per share of Class A Common Stock. The quarterly cash dividend was payable on September 11, 2023 to stockholders of record on August 10, 2023.
AstraZeneca’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for AstraZeneca.
AstraZeneca is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
AstraZeneca Stock (NASDAQ: AZN) stock price, news, charts, stock research, profile.
Open68.370 | Close- |
Vol / Avg.2.900M / 5.219M | Mkt Cap211.298B |
Day Range68.005 - 68.505 | 52 Wk Range52.655 - 76.560 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.950 | 1.075 | |||||
REV | 10.960B | 11.416B | 456.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-08 | Erste Group | - | Downgrades | BuyHold | - | - | - |
2023-08-01 | BMO Capital | Etzer Darout | Maintains | OutperformOutperform | Raises | 81.00 | 83.00 |
2023-05-26 | Argus Research | Jasper Hellweg | Maintains | BuyBuy | Lowers | 85.00 | 80.00 |
2023-04-13 | Argus Research | Jasper Hellweg | Maintains | Buy | Raises | 75.00 | 85.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
AZN | AstraZeneca | 1.71% | 211.3B |
NVO | Novo Nordisk | 0.43% | 410.1B |
RETA | Reata Pharmaceuticals | 0.06% | 6.6B |
JNJ | Johnson & Johnson | -0.45% | 387.5B |
MRK | Merck & Co | -0.11% | 270.5B |
You can purchase shares of AstraZeneca (NASDAQ: AZN) through any online brokerage.
Other companies in AstraZeneca’s space includes: Novo Nordisk (NYSE:NVO), Reata Pharmaceuticals (NASDAQ:RETA), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK) and Novartis (NYSE:NVS).
The latest price target for AstraZeneca (NASDAQ: AZN) was reported by Erste Group on Friday, September 8, 2023. The analyst firm set a price target for 0.00 expecting AZN to fall to within 12 months (a possible -100.00% downside). 7 analyst firms have reported ratings in the last year.
The stock price for AstraZeneca (NASDAQ: AZN) is $68.165 last updated Today at September 22, 2023 at 5:55 PM UTC.
A quarterly cash dividend of $0.47 per share of Class A Common Stock. The quarterly cash dividend was payable on September 11, 2023 to stockholders of record on August 10, 2023.
AstraZeneca’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for AstraZeneca.
AstraZeneca is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
AstraZeneca Stock (NASDAQ: AZN) stock price, news, charts, stock research, profile.
Open68.370 | Close- |
Vol / Avg.2.900M / 5.219M | Mkt Cap211.298B |
Day Range68.005 - 68.505 | 52 Wk Range52.655 - 76.560 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.950 | 1.075 | |||||
REV | 10.960B | 11.416B | 456.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-08 | Erste Group | - | Downgrades | BuyHold | - | - | - |
2023-08-01 | BMO Capital | Etzer Darout | Maintains | OutperformOutperform | Raises | 81.00 | 83.00 |
2023-05-26 | Argus Research | Jasper Hellweg | Maintains | BuyBuy | Lowers | 85.00 | 80.00 |
2023-04-13 | Argus Research | Jasper Hellweg | Maintains | Buy | Raises | 75.00 | 85.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
AZN | AstraZeneca | 1.71% | 211.3B |
NVO | Novo Nordisk | 0.43% | 410.1B |
RETA | Reata Pharmaceuticals | 0.06% | 6.6B |
JNJ | Johnson & Johnson | -0.45% | 387.5B |
MRK | Merck & Co | -0.11% | 270.5B |
You can purchase shares of AstraZeneca (NASDAQ: AZN) through any online brokerage.
Other companies in AstraZeneca’s space includes: Novo Nordisk (NYSE:NVO), Reata Pharmaceuticals (NASDAQ:RETA), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK) and Novartis (NYSE:NVS).
The latest price target for AstraZeneca (NASDAQ: AZN) was reported by Erste Group on Friday, September 8, 2023. The analyst firm set a price target for 0.00 expecting AZN to fall to within 12 months (a possible -100.00% downside). 7 analyst firms have reported ratings in the last year.
The stock price for AstraZeneca (NASDAQ: AZN) is $68.165 last updated Today at September 22, 2023 at 5:55 PM UTC.
A quarterly cash dividend of $0.47 per share of Class A Common Stock. The quarterly cash dividend was payable on September 11, 2023 to stockholders of record on August 10, 2023.
AstraZeneca’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for AstraZeneca.
AstraZeneca is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
AstraZeneca Stock (NASDAQ: AZN) stock price, news, charts, stock research, profile.
Open68.370 | Close- |
Vol / Avg.2.900M / 5.219M | Mkt Cap211.298B |
Day Range68.005 - 68.505 | 52 Wk Range52.655 - 76.560 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.950 | 1.075 | |||||
REV | 10.960B | 11.416B | 456.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-08 | Erste Group | - | Downgrades | BuyHold | - | - | - |
2023-08-01 | BMO Capital | Etzer Darout | Maintains | OutperformOutperform | Raises | 81.00 | 83.00 |
2023-05-26 | Argus Research | Jasper Hellweg | Maintains | BuyBuy | Lowers | 85.00 | 80.00 |
2023-04-13 | Argus Research | Jasper Hellweg | Maintains | Buy | Raises | 75.00 | 85.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
AZN | AstraZeneca | 1.71% | 211.3B |
NVO | Novo Nordisk | 0.43% | 410.1B |
RETA | Reata Pharmaceuticals | 0.06% | 6.6B |
JNJ | Johnson & Johnson | -0.45% | 387.5B |
MRK | Merck & Co | -0.11% | 270.5B |
You can purchase shares of AstraZeneca (NASDAQ: AZN) through any online brokerage.
Other companies in AstraZeneca’s space includes: Novo Nordisk (NYSE:NVO), Reata Pharmaceuticals (NASDAQ:RETA), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK) and Novartis (NYSE:NVS).
The latest price target for AstraZeneca (NASDAQ: AZN) was reported by Erste Group on Friday, September 8, 2023. The analyst firm set a price target for 0.00 expecting AZN to fall to within 12 months (a possible -100.00% downside). 7 analyst firms have reported ratings in the last year.
The stock price for AstraZeneca (NASDAQ: AZN) is $68.165 last updated Today at September 22, 2023 at 5:55 PM UTC.
A quarterly cash dividend of $0.47 per share of Class A Common Stock. The quarterly cash dividend was payable on September 11, 2023 to stockholders of record on August 10, 2023.
AstraZeneca’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for AstraZeneca.
AstraZeneca is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
AstraZeneca Stock (NASDAQ: AZN) stock price, news, charts, stock research, profile.
Open68.370 | Close- |
Vol / Avg.2.900M / 5.219M | Mkt Cap211.298B |
Day Range68.005 - 68.505 | 52 Wk Range52.655 - 76.560 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.950 | 1.075 | |||||
REV | 10.960B | 11.416B | 456.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-08 | Erste Group | - | Downgrades | BuyHold | - | - | - |
2023-08-01 | BMO Capital | Etzer Darout | Maintains | OutperformOutperform | Raises | 81.00 | 83.00 |
2023-05-26 | Argus Research | Jasper Hellweg | Maintains | BuyBuy | Lowers | 85.00 | 80.00 |
2023-04-13 | Argus Research | Jasper Hellweg | Maintains | Buy | Raises | 75.00 | 85.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
AZN | AstraZeneca | 1.71% | 211.3B |
NVO | Novo Nordisk | 0.43% | 410.1B |
RETA | Reata Pharmaceuticals | 0.06% | 6.6B |
JNJ | Johnson & Johnson | -0.45% | 387.5B |
MRK | Merck & Co | -0.11% | 270.5B |
You can purchase shares of AstraZeneca (NASDAQ: AZN) through any online brokerage.
Other companies in AstraZeneca’s space includes: Novo Nordisk (NYSE:NVO), Reata Pharmaceuticals (NASDAQ:RETA), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK) and Novartis (NYSE:NVS).
The latest price target for AstraZeneca (NASDAQ: AZN) was reported by Erste Group on Friday, September 8, 2023. The analyst firm set a price target for 0.00 expecting AZN to fall to within 12 months (a possible -100.00% downside). 7 analyst firms have reported ratings in the last year.
The stock price for AstraZeneca (NASDAQ: AZN) is $68.165 last updated Today at September 22, 2023 at 5:55 PM UTC.
A quarterly cash dividend of $0.47 per share of Class A Common Stock. The quarterly cash dividend was payable on September 11, 2023 to stockholders of record on August 10, 2023.
AstraZeneca’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for AstraZeneca.
AstraZeneca is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
AstraZeneca Stock (NASDAQ: AZN) stock price, news, charts, stock research, profile.
Open68.370 | Close- |
Vol / Avg.2.900M / 5.219M | Mkt Cap211.298B |
Day Range68.005 - 68.505 | 52 Wk Range52.655 - 76.560 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.950 | 1.075 | |||||
REV | 10.960B | 11.416B | 456.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-08 | Erste Group | - | Downgrades | BuyHold | - | - | - |
2023-08-01 | BMO Capital | Etzer Darout | Maintains | OutperformOutperform | Raises | 81.00 | 83.00 |
2023-05-26 | Argus Research | Jasper Hellweg | Maintains | BuyBuy | Lowers | 85.00 | 80.00 |
2023-04-13 | Argus Research | Jasper Hellweg | Maintains | Buy | Raises | 75.00 | 85.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
AZN | AstraZeneca | 1.71% | 211.3B |
NVO | Novo Nordisk | 0.43% | 410.1B |
RETA | Reata Pharmaceuticals | 0.06% | 6.6B |
JNJ | Johnson & Johnson | -0.45% | 387.5B |
MRK | Merck & Co | -0.11% | 270.5B |
You can purchase shares of AstraZeneca (NASDAQ: AZN) through any online brokerage.
Other companies in AstraZeneca’s space includes: Novo Nordisk (NYSE:NVO), Reata Pharmaceuticals (NASDAQ:RETA), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK) and Novartis (NYSE:NVS).
The latest price target for AstraZeneca (NASDAQ: AZN) was reported by Erste Group on Friday, September 8, 2023. The analyst firm set a price target for 0.00 expecting AZN to fall to within 12 months (a possible -100.00% downside). 7 analyst firms have reported ratings in the last year.
The stock price for AstraZeneca (NASDAQ: AZN) is $68.165 last updated Today at September 22, 2023 at 5:55 PM UTC.
A quarterly cash dividend of $0.47 per share of Class A Common Stock. The quarterly cash dividend was payable on September 11, 2023 to stockholders of record on August 10, 2023.
AstraZeneca’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for AstraZeneca.
AstraZeneca is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
AstraZeneca Stock (NASDAQ: AZN) stock price, news, charts, stock research, profile.
Open68.370 | Close- |
Vol / Avg.2.900M / 5.219M | Mkt Cap211.298B |
Day Range68.005 - 68.505 | 52 Wk Range52.655 - 76.560 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.950 | 1.075 | |||||
REV | 10.960B | 11.416B | 456.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-08 | Erste Group | - | Downgrades | BuyHold | - | - | - |
2023-08-01 | BMO Capital | Etzer Darout | Maintains | OutperformOutperform | Raises | 81.00 | 83.00 |
2023-05-26 | Argus Research | Jasper Hellweg | Maintains | BuyBuy | Lowers | 85.00 | 80.00 |
2023-04-13 | Argus Research | Jasper Hellweg | Maintains | Buy | Raises | 75.00 | 85.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
AZN | AstraZeneca | 1.71% | 211.3B |
NVO | Novo Nordisk | 0.43% | 410.1B |
RETA | Reata Pharmaceuticals | 0.06% | 6.6B |
JNJ | Johnson & Johnson | -0.45% | 387.5B |
MRK | Merck & Co | -0.11% | 270.5B |
You can purchase shares of AstraZeneca (NASDAQ: AZN) through any online brokerage.
Other companies in AstraZeneca’s space includes: Novo Nordisk (NYSE:NVO), Reata Pharmaceuticals (NASDAQ:RETA), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK) and Novartis (NYSE:NVS).
The latest price target for AstraZeneca (NASDAQ: AZN) was reported by Erste Group on Friday, September 8, 2023. The analyst firm set a price target for 0.00 expecting AZN to fall to within 12 months (a possible -100.00% downside). 7 analyst firms have reported ratings in the last year.
The stock price for AstraZeneca (NASDAQ: AZN) is $68.165 last updated Today at September 22, 2023 at 5:55 PM UTC.
A quarterly cash dividend of $0.47 per share of Class A Common Stock. The quarterly cash dividend was payable on September 11, 2023 to stockholders of record on August 10, 2023.
AstraZeneca’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for AstraZeneca.
AstraZeneca is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
AstraZeneca Stock (NASDAQ: AZN) stock price, news, charts, stock research, profile.
Open68.370 | Close- |
Vol / Avg.2.900M / 5.219M | Mkt Cap211.298B |
Day Range68.005 - 68.505 | 52 Wk Range52.655 - 76.560 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.950 | 1.075 | |||||
REV | 10.960B | 11.416B | 456.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-08 | Erste Group | - | Downgrades | BuyHold | - | - | - |
2023-08-01 | BMO Capital | Etzer Darout | Maintains | OutperformOutperform | Raises | 81.00 | 83.00 |
2023-05-26 | Argus Research | Jasper Hellweg | Maintains | BuyBuy | Lowers | 85.00 | 80.00 |
2023-04-13 | Argus Research | Jasper Hellweg | Maintains | Buy | Raises | 75.00 | 85.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
AZN | AstraZeneca | 1.71% | 211.3B |
NVO | Novo Nordisk | 0.43% | 410.1B |
RETA | Reata Pharmaceuticals | 0.06% | 6.6B |
JNJ | Johnson & Johnson | -0.45% | 387.5B |
MRK | Merck & Co | -0.11% | 270.5B |
You can purchase shares of AstraZeneca (NASDAQ: AZN) through any online brokerage.
Other companies in AstraZeneca’s space includes: Novo Nordisk (NYSE:NVO), Reata Pharmaceuticals (NASDAQ:RETA), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK) and Novartis (NYSE:NVS).
The latest price target for AstraZeneca (NASDAQ: AZN) was reported by Erste Group on Friday, September 8, 2023. The analyst firm set a price target for 0.00 expecting AZN to fall to within 12 months (a possible -100.00% downside). 7 analyst firms have reported ratings in the last year.
The stock price for AstraZeneca (NASDAQ: AZN) is $68.165 last updated Today at September 22, 2023 at 5:55 PM UTC.
A quarterly cash dividend of $0.47 per share of Class A Common Stock. The quarterly cash dividend was payable on September 11, 2023 to stockholders of record on August 10, 2023.
AstraZeneca’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for AstraZeneca.
AstraZeneca is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
AstraZeneca Stock (NASDAQ: AZN) stock price, news, charts, stock research, profile.
Open68.370 | Close- |
Vol / Avg.2.900M / 5.219M | Mkt Cap211.298B |
Day Range68.005 - 68.505 | 52 Wk Range52.655 - 76.560 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.950 | 1.075 | |||||
REV | 10.960B | 11.416B | 456.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-08 | Erste Group | - | Downgrades | BuyHold | - | - | - |
2023-08-01 | BMO Capital | Etzer Darout | Maintains | OutperformOutperform | Raises | 81.00 | 83.00 |
2023-05-26 | Argus Research | Jasper Hellweg | Maintains | BuyBuy | Lowers | 85.00 | 80.00 |
2023-04-13 | Argus Research | Jasper Hellweg | Maintains | Buy | Raises | 75.00 | 85.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
AZN | AstraZeneca | 1.71% | 211.3B |
NVO | Novo Nordisk | 0.43% | 410.1B |
RETA | Reata Pharmaceuticals | 0.06% | 6.6B |
JNJ | Johnson & Johnson | -0.45% | 387.5B |
MRK | Merck & Co | -0.11% | 270.5B |
You can purchase shares of AstraZeneca (NASDAQ: AZN) through any online brokerage.
Other companies in AstraZeneca’s space includes: Novo Nordisk (NYSE:NVO), Reata Pharmaceuticals (NASDAQ:RETA), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK) and Novartis (NYSE:NVS).
The latest price target for AstraZeneca (NASDAQ: AZN) was reported by Erste Group on Friday, September 8, 2023. The analyst firm set a price target for 0.00 expecting AZN to fall to within 12 months (a possible -100.00% downside). 7 analyst firms have reported ratings in the last year.
The stock price for AstraZeneca (NASDAQ: AZN) is $68.165 last updated Today at September 22, 2023 at 5:55 PM UTC.
A quarterly cash dividend of $0.47 per share of Class A Common Stock. The quarterly cash dividend was payable on September 11, 2023 to stockholders of record on August 10, 2023.
AstraZeneca’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for AstraZeneca.
AstraZeneca is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.